Resources from the same session
LBA38 - Pembrolizumab versus cetuximab, concomitant with radiotherapy (RT) in locally advanced head and neck squamous cell carcinoma (LA-HNSCC): Results of the GORTEC 2015-01 “PembroRad” randomized trial
Presenter: Yungan Tao
Session: Proffered Paper - Head & Neck cancer
Resources:
Abstract
Slides
Webcast
910O - Primary results of the phase III JAVELIN head & neck 100 trial: Avelumab plus chemoradiotherapy (CRT) followed by avelumab maintenance vs CRT in patients with locally advanced squamous cell carcinoma of the head and neck (LA SCCHN)
Presenter: Ezra Cohen
Session: Proffered Paper - Head & Neck cancer
Resources:
Abstract
Slides
Webcast
LBA39 - 3-years follow-up of double-blind randomized phase II comparing concurrent high-dose cisplatin chemo-radiation plus xevinapant or placebo in high-risk patients with locally advanced squamous cell carcinoma of the head and neck
Presenter: Jean Bourhis
Session: Proffered Paper - Head & Neck cancer
Resources:
Abstract
Slides
Webcast
LBA40 - Neoadjuvant nivolumab and nivolumab plus ipilimumab induce (near-) complete responses in patients with head and neck squamous cell carcinoma: The IMCISION trial
Presenter: Lotje Zuur
Session: Proffered Paper - Head & Neck cancer
Resources:
Abstract
Slides
Webcast
911O - Performance of dual p16 and HPV testing for determining prognosis in cancer of the oropharynx, the EPIC-OPC Study
Presenter: Miren Taberna
Session: Proffered Paper - Head & Neck cancer
Resources:
Abstract
Slides
Webcast
Invited Discussant LBA38, 910O and LBA39
Presenter: Sjoukje Oosting
Session: Proffered Paper - Head & Neck cancer
Resources:
Slides
Webcast
Q&A and live discussion
Presenter: Anthony T.C. Chan
Session: Proffered Paper - Head & Neck cancer
Resources:
Webcast
Q&A and live discussion
Presenter: Anthony T.C. Chan
Session: Proffered Paper - Head & Neck cancer
Resources:
Webcast